Annual EBITDA
$494.50 M
-$285.70 M-36.62%
December 31, 2023
Summary
- As of February 7, 2025, CWK annual EBITDA is $494.50 million, with the most recent change of -$285.70 million (-36.62%) on December 31, 2023.
- During the last 3 years, CWK annual EBITDA has risen by +$108.70 million (+28.18%).
- CWK annual EBITDA is now -37.85% below its all-time high of $795.70 million, reached on December 31, 2021.
Performance
CWK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$140.70 M
-$1.70 M-1.19%
September 30, 2024
Summary
- As of February 7, 2025, CWK quarterly EBITDA is $140.70 million, with the most recent change of -$1.70 million (-1.19%) on September 30, 2024.
- Over the past year, CWK quarterly EBITDA has dropped by -$54.40 million (-27.88%).
- CWK quarterly EBITDA is now -55.45% below its all-time high of $315.80 million, reached on December 31, 2021.
Performance
CWK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$564.90 M
+$14.60 M+2.65%
September 30, 2024
Summary
- As of February 7, 2025, CWK TTM EBITDA is $564.90 million, with the most recent change of +$14.60 million (+2.65%) on September 30, 2024.
- Over the past year, CWK TTM EBITDA has increased by +$71.70 million (+14.54%).
- CWK TTM EBITDA is now -39.95% below its all-time high of $940.70 million, reached on June 30, 2022.
Performance
CWK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CWK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.6% | -27.9% | +14.5% |
| 3 y3 years | +28.2% | +186.0% | -12.3% |
| 5 y5 years | +62.6% | +0.4% | -7.3% |
CWK EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.9% | at low | -55.5% | +186.0% | -40.0% | +14.5% |
| 5 y | 5-year | -37.9% | +28.2% | -55.5% | +248.3% | -40.0% | +46.4% |
| alltime | all time | -37.9% | +1056.5% | -55.5% | +346.4% | -40.0% | +1089.3% |
Cushman & Wakefield EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $140.70 M(-1.2%) | $564.90 M(+2.7%) |
| Jun 2024 | - | $142.40 M(+64.2%) | $550.30 M(+3.7%) |
| Mar 2024 | - | $86.70 M(-55.6%) | $530.70 M(+7.6%) |
| Dec 2023 | $494.50 M(-36.6%) | $195.10 M(+54.7%) | $493.20 M(-1.8%) |
| Sep 2023 | - | $126.10 M(+2.7%) | $502.20 M(-5.9%) |
| Jun 2023 | - | $122.80 M(+149.6%) | $533.70 M(-17.2%) |
| Mar 2023 | - | $49.20 M(-75.9%) | $644.40 M(-17.4%) |
| Dec 2022 | $780.20 M(-1.9%) | $204.10 M(+29.5%) | $780.20 M(-12.5%) |
| Sep 2022 | - | $157.60 M(-32.5%) | $891.90 M(-5.2%) |
| Jun 2022 | - | $233.50 M(+26.2%) | $940.70 M(+3.0%) |
| Mar 2022 | - | $185.00 M(-41.4%) | $913.40 M(+14.8%) |
| Dec 2021 | $795.70 M(+106.2%) | $315.80 M(+53.0%) | $795.70 M(+18.3%) |
| Sep 2021 | - | $206.40 M(+0.1%) | $672.80 M(+17.4%) |
| Jun 2021 | - | $206.20 M(+206.4%) | $573.30 M(+38.9%) |
| Mar 2021 | - | $67.30 M(-65.1%) | $412.70 M(+7.0%) |
| Dec 2020 | $385.80 M | $192.90 M(+80.4%) | $385.80 M(-9.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $106.90 M(+134.4%) | $427.10 M(-7.2%) |
| Jun 2020 | - | $45.60 M(+12.9%) | $460.30 M(-19.4%) |
| Mar 2020 | - | $40.40 M(-82.7%) | $570.80 M(-6.4%) |
| Dec 2019 | $609.60 M(+100.5%) | $234.20 M(+67.2%) | $609.60 M(+23.3%) |
| Sep 2019 | - | $140.10 M(-10.2%) | $494.30 M(+11.0%) |
| Jun 2019 | - | $156.10 M(+97.1%) | $445.20 M(+15.6%) |
| Mar 2019 | - | $79.20 M(-33.4%) | $385.00 M(+26.6%) |
| Dec 2018 | $304.10 M(+137.6%) | $118.90 M(+30.7%) | $304.10 M(-4.5%) |
| Sep 2018 | - | $91.00 M(-5.1%) | $318.40 M(+33.0%) |
| Jun 2018 | - | $95.90 M(-5741.2%) | $239.40 M(+30.5%) |
| Mar 2018 | - | -$1.70 M(-101.3%) | $183.40 M(+43.3%) |
| Dec 2017 | $128.00 M(-4840.7%) | $133.20 M(+1010.0%) | $128.00 M(-2561.5%) |
| Sep 2017 | - | $12.00 M(-69.9%) | -$5.20 M(-69.8%) |
| Jun 2017 | - | $39.90 M(-169.9%) | -$17.20 M(-69.9%) |
| Mar 2017 | - | -$57.10 M | -$57.10 M |
| Dec 2016 | -$2.70 M(-94.8%) | - | - |
| Dec 2015 | -$51.70 M | - | - |
FAQ
- What is Cushman & Wakefield annual EBITDA?
- What is the all time high annual EBITDA for Cushman & Wakefield?
- What is Cushman & Wakefield annual EBITDA year-on-year change?
- What is Cushman & Wakefield quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cushman & Wakefield?
- What is Cushman & Wakefield quarterly EBITDA year-on-year change?
- What is Cushman & Wakefield TTM EBITDA?
- What is the all time high TTM EBITDA for Cushman & Wakefield?
- What is Cushman & Wakefield TTM EBITDA year-on-year change?
What is Cushman & Wakefield annual EBITDA?
The current annual EBITDA of CWK is $494.50 M
What is the all time high annual EBITDA for Cushman & Wakefield?
Cushman & Wakefield all-time high annual EBITDA is $795.70 M
What is Cushman & Wakefield annual EBITDA year-on-year change?
Over the past year, CWK annual EBITDA has changed by -$285.70 M (-36.62%)
What is Cushman & Wakefield quarterly EBITDA?
The current quarterly EBITDA of CWK is $140.70 M
What is the all time high quarterly EBITDA for Cushman & Wakefield?
Cushman & Wakefield all-time high quarterly EBITDA is $315.80 M
What is Cushman & Wakefield quarterly EBITDA year-on-year change?
Over the past year, CWK quarterly EBITDA has changed by -$54.40 M (-27.88%)
What is Cushman & Wakefield TTM EBITDA?
The current TTM EBITDA of CWK is $564.90 M
What is the all time high TTM EBITDA for Cushman & Wakefield?
Cushman & Wakefield all-time high TTM EBITDA is $940.70 M
What is Cushman & Wakefield TTM EBITDA year-on-year change?
Over the past year, CWK TTM EBITDA has changed by +$71.70 M (+14.54%)